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Background: The assessment of health-related quality of life (HRQoL) in people living with HIV (PLHIV) has become
crucial to evidence-based practice. The goals of this study are to analyze the psychometric properties and evidence
of the validity of the Spanish version of WHOQOL-HIV-BREF in a sample of PLHIV in Spain and to examine the more
impaired HRQoL facets and dimensions and identify the PLHIV who show the most vulnerable profile.
Methods: A total of 1462 PLHIV participated in an observational cross-sectional ex-post-facto study. Data were
collected at 33 Spanish sites through an online survey. In addition to measuring HRQoL, the study used other tools
to measure treatment adherence (CEAT-VIH 2.0 version), psychological well-being (GHQ-12) and HIV-related stigma
(HSSS). Cronbach’s alpha, first- and second-order confirmatory factor analysis (CFA), the Pearson coefficient and one-
way ANOVA were used to evaluate reliability, construct validity and concurrent and known-group validity,
respectively. Differences according to the socio-demographic and epidemiological profiles of participants were
analyzed.
Results: First- and second-order CFAs confirmed a six-domain first-order structure of the Spanish version of
WHOQOL-HIV-BREF and one second-order factor related to overall HRQoL with an acceptable fit to the data,
although some minor changes would improve it. The six-domain structure showed an acceptable internal
consistency (Cronbach’s alpha ranged from .61 to .81). Significant moderate to large correlations between domains
and overall HRQoL, adherence, psychological well-being and negative self-image were found. Significant differences
were found according to participants’ self-reported CD4+ cell count in several HRQoL facets and domains. Being
female, heterosexual, having low socio-economic and educational statuses, having acquired HIV through an unsafe
injection and living more years with HIV were related to poorer HRQoL. PLHIV older than 50 presented lower scores
in 19 HRQoL facets.
Conclusions: This study demonstrates that the Spanish version of the WHOQOL-HIV-BREF is a valid instrument. It
also presents the most recent data about HRQoL in PLHIV in Spain with the largest sample to date.
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An estimated 36.7 million people are living with HIV
worldwide [1]. Spain has an estimated 145,000 people
living with HIV (PLHIV) [2], and there were 3353 new
HIV diagnoses in 2016 [3]. While AIDS cases have de-
clined in Spain in recent years with the use of effective
antiretroviral therapy (ART) regimens, late diagnosis re-
mains a problem. In more than one-quarter of new diag-
noses in 2016, the person diagnosed had a CD4 cell
count of less than 200, indicating advanced disease [3].
Improvements in ART have resulted in increased life ex-
pectancy for many PLHIV. Nonetheless, HIV infection and
its related problems still have a notable impact on health-
related quality of life (HRQoL), even in people who are vir-
ally suppressed as a result of taking ART [4]. Helping
PLHIV achieve good outcomes in regard to their
HRQoL requires understanding its determinants in
this population. Studies have identified a number of
factors that are consistently associated with HRQoL
among PLHIV, including ageing, immunological sta-
tus, the presence of symptoms, treatment adherence,
depression, social support, employment and HIV-
related stigma [5, 6].
In this context, the precise assessment of HRQoL with a
valid measure has become crucial to the improvement of
quality of life of PLHIV [7]. Additionally, HRQoL assess-
ment has a major role in evaluating intervention outcomes
[8]. Several instruments, both generic and HIV-specific,
have been used to measure HRQoL in PLHIV. Generic in-
struments such as the widely used EQ-5D and SF-36 have
the advantage of yielding findings that can be compared to
HRQoL findings for the general population. However,
HIV-specific instruments have shown greater sensitivity
than generic ones [9]. WHOQOL-HIV-BREF [8] is consid-
ered to be one of the most promising of the HIV-specific
instruments because of its psychometric properties, rele-
vance to PLHIV and cross-cultural validity [9].
WHOQOL-HIV-BREF is the short version of WHOQOL-
HIV [7]. Both instruments contain facets (individual compo-
nents) of the generic WHOQOL measure [10] as well as
HIV-specific facets. WHOQOL-HIV-BREF includes 29 items
covering six domains: physical, psychological, level of inde-
pendence, social, environmental and spiritual. There is also a
two-item general facet.
The generic WHOQOL instrument has been validated
in Spain [11]. However, there are no studies reporting
the use of WHOQOL-HIV-BREF with Spanish PLHIV.
This study aimed to assess the psychometric properties
and evidence of the validity of the Spanish version of
WHOQOL-HIV-BREF in a large sample of people with
HIV in Spain. Furthermore, it aimed to determine which
HRQoL facets and dimensions are most impaired and
which groups of PLHIV are more vulnerable to these
outcomes.Methods
Study population and procedures
An observational cross-sectional ex-post-facto study was
conducted in which 1462 PLHIV participated. They were
recruited by convenience sampling. The general inclu-
sion criteria were positive HIV diagnosis, being at least
18 years old, on antiretroviral therapy (ART) for at least
one year, and not having any severe psychiatric or cogni-
tive disorder. Data were collected between October 2016
and April 2017.
An online survey was designed using the Qualtrics
survey platform (available at: www.qualtrics.com). Qual-
trics is a private online survey development platform
that allows the creation of surveys which can be accessed
through a link. In the present study, our survey was self-
administered with the support of tablet computers. Ser-
vice providers from 33 service delivery points across
Spain (hospitals and NGOs) collaborated in the partici-
pants’ recruitment and data collection. During their
medical consultations or when attending various ser-
vices, the collaborating service providers explained the
goals of the study to the participants, requesting their
participation and obtaining their informed consent. The
rate of refusal to participate in the study varied across
centers, ranging from 0 to 18%, with an average around
7%. The main reasons argued for the refusal were not
having enough time, the survey length or lack of skills to
use tablets. Participants were compensated with 15
euros.
The Ethics Committee of the Hospital Clínico of Val-
encia approved the research protocol in March 2016. All
study procedures were conducted in accordance with
the 1964 Helsinki Declaration (revised in 1996) [12].
Measures
WHOQOL-HIV-BREF
WHOQOL-HIV-BREF has 31 items covering six do-
mains: physical health; psychological health; level of in-
dependence; social relationship; environmental health;
and spirituality, religion and personal beliefs (SRPB) [8].
Responses to all items are given on a 5-point scale.
Items that ask about negative perceptions and experi-
ences, such as “How much do you fear the future?” are
reverse-coded for scoring. Thus, higher scores for all
items indicate better quality of life. The average score
for each domain is multiplied by four, yielding domain
scores that range from 4 to 20 [13].
Several studies have examined the validity and psycho-
metric properties of WHOQOL-HIV-BREF in different
languages and countries. (A summary of these studies is
presented in Additional file 1). They have found the
instrument to have good psychometric properties and
have also found evidence of its validity. The Spiritual,
Religion and Personal Beliefs domain (SRPB) is the
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discriminative power in most of the studies [8, 14–18],
although it is the domain which contains more
HIV-specific items measuring existential concerns
relating to HIV.
Because WHOQOL-BREF has been validated in a
Spanish study population [19], only the translation of
the HIV-specific items was needed (see Additional file 2).
The HIV-specific items collect information about the
bother caused by physical problems related to HIV
infection, HIV-related stigma, and fears related to the
future and to death (“How much are you bothered by
any physical problems related to your HIV infection?,”
“To what extent are you bothered by people blaming
you for your HIV status?,” “How much do you fear
the future?,” “How much do you worry about death?,”
and “To what extent do you feel accepted by the
people you know?”). These items were extracted from
five HIV facets of the WHOQOL-HIV long form and
then integrated with the WHOQOL-BREF to
complete the 31-item WHOQOL-HIV BREF [8]. They
were translated following the criteria of the Inter-
national Test Commission [20]. A backward transla-
tion was performed by two expert translators. In
addition, a person with HIV reviewed the translation.
Questionnaire to evaluate the adherence to HIV therapy
(CEAT-VIH 2.0 version)
The validated Spanish version of the Questionnaire
to Evaluate the Adherence to HIV Therapy (CEAT-
VIH 2.0 version) [21–23] was used. This scale is
comprised of 17 items rated on a 5-point scale.
Negative items were reverse-coded. A composite of
all items (total score) was calculated, with higher the
scores indicating higher treatment adherence. A
systematic review of the psychometric properties of
the CEAT-VIH including 20 studies revealed an
adequate internal consistency as well as no floor or
ceiling effects [23]. Additionally, evidence of validity
comprised criterion-related validity (e.g., HIV viral
load, length of time with continuous undetectable
HIV viral load, days of missed doses, number of pills
per day, and adherence assessed by the pharmacist or
physician); responsiveness, sensitivity, and specificity;
and patterns of convergence and divergence (e.g.,
negative mood, depression, anxiety and stress were
negatively associated with CEAT-VIH scores whereas
positive correlations with CEAT-VIH scores were
found for perceived social support and quality of life
outcomes).
General Health Questionnaire (GHQ-12)
The validated Spanish version of the General Health
Questionnaire (GHQ-12) was used [24]. Items are ratedon a 4-point scale, with higher scores indicating better
psychological health. In previous studies, this scale has
shown adequate reliability and validity in the Spanish
general population [24].
HIV-related stigma
Five items of the Negative Self-image dimension and
three items of the Disclosure Concerns dimension of the
Spanish HIV Stigma Scale (HSSS) were used [25]. These
items were selected for having higher validity constructs
in the validation study of the scale. A previous study in
Spain revealed that this scale shows good internal
consistency and good construct validity, including con-
tent and criterion validity [25]. The items are rated on a
4-point scale.
Self-reported questions related to health status such years
living with HIV, lymphocyte CD4 count and viral load cop-
ies were included in the survey. Moreover, the question-
naire also measured socio-demographic information.
Data analysis
Completing most items of the online questionnaire in
the Qualtrics survey platform was programmed to be
compulsory. Only items related to some sensitive char-
acteristics of the participants were allowed to be skipped.
Thus, there were no missing values in the tools used to
measure the variables under analysis.
To test the construct validity, first-order confirmatory
factor analysis (CFA) was used to assess the fit of the
Spanish version of the WHOQOL-HIV-BREF to the six-
dimension original structure (Model 1, [8]). Next,
second-order CFA was performed to determine whether
the six first-order factors could be explained by a
higher-order latent factor associated with HRQoL. Previ-
ous studies showed that one of the items of the SRPB di-
mension presented a low facet-domain correlation [18]
or factor loading [14, 17] and was saturated in the psy-
chological domain rather than in the existential domain
when exploratory factor analysis (EFA) was conducted
[16]. Thus, we tested an alternative model (Model 2)
allowing one of the items of the SRPB dimension—feel-
ings of personal meaning—to load in the Psychological
Health latent dimension. The robust unweighted least
square method was used because the items in the scale
did not meet the assumption of normality. Goodness of
fit was evaluated using the goodness of fit index (GFI),
the adjusted goodness of fit index (AGFI), the compara-
tive fit index (CFI), the standardized root mean square
residual (SRMR) and the standardized root mean square
error of approximation (RMSEA). Also, the consistent
Akaike information criterion (CAIC) was used to com-
pare the alternative models. According to Hu and Ben-
tler [26], the models are considered to have a good fit
Table 1 Sociodemographic and clinical characteristics of the
participants (N = 1462)
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CFI > .90, RMSEA < .08 and SRMR <.08. The reliability
of each domain was assessed using Cronbach’s α
coefficient.
Pearson’s correlation analysis between domain scores
and the general health dimension of WHOQOL-HIV-
BREF was performed for convergent validity. To assess
concurrent validity, we examine the association between
domain scores and the criterion variables measured. We
expected to find positive correlations between domain
scores and CEAT-VIH and GHQ-12. We also expected
to find negative correlations between domain scores and
HIV-related stigma dimensions.
Known-group validity was used to assess the capacity of
WHOQOL-HIV-BREF to discriminate among subgroups of
participants according to their immunological (CD4 count)
and virological (viral load copies) status. It was expected that
participants with higher CD4 count and undetectable viral
load would have higher HRQoL domain scores.
Finally, differences according to the socio-demographic
and epidemiological profiles of study participants were ana-
lyzed. For the sake of simplicity and clarity, only differences
in the domains were assessed in most of the characteristics
of the participants, and only p-values are shown. However,
differences in all HRQoL facets were tested according to
age and sex. It was done because of the current relevance
of analyzing HRQoL in aging PLHIV and the UNAIDS rec-
ommendations about disaggregation of data according to
relevant socio-demographic characteristics [27]. To test dif-
ferences by age, a cut-off point of 49 years (≤ 49 vs. ≥ 50
years) was established. T-test and one-way variance analysis
were used for these analyses.
Regarding the data analysis software, LISREL (LInear
Structural RELations) 8.7 program and its companion pre-
processor program PRELIS for Windows were used for
the CFAs. LISREL is an application for structural equation
modeling developed by K. G. Jöreskog and D. Sörborm
[28]. PRELIS is an application for data manipulation, data
transformation, data generation, computing moment
matrices and imputation by matching. A widely used pro-
gram for statistical analysis in social science, IBM SPSS
Statistics 22 [29], was selected for the remaining analyses.Other 3





Duration of infection, years, mean (M ± SD) 13.8 ± 9.6Results
Sample characteristics
Socio-demographic and health data of the participants
are shown in Table 1. The epidemiological profile
found was concordant with Spanish epidemiological
data for PLHIV [3].Years taking antiretroviral therapy (M ± SD) 11.3 ± 8.3
Undetectable plasma viral load 90.4
Note: Data in percentages unless otherwise statedWHOQOL-HIV-BREF scores
The descriptive statistics of each item and domain are dis-
played in Table 2. The mean scores of the WHOQOL-
Table 2 Descriptive statistics and reliability of the domains and items (N = 1462)
Domains and items Mean (± SD) Skewness Kurtosis Corrected item-domain
correlation
Cronbach’s α if item
is deleted
Overall QoL/General Health (α = .77) 14.9 ± 3.6
How would you rate your QoL? 3.6 ± 1.06 −.40 −.63 .63
How satisfied are you with your health? 3.8 ± .93 −.94 .78 .63
Physical health (α = .73) 15.5 ± 3.2
Pain and discomforta 3.9 ± 1.1 −.87 −.39 .58 .64
Symptoms of HIVa 4.2 ± 1.0 −1.2 .55 .54 .66
Energy and fatigue 3.9 ± .97 −.77 .05 .56 .65
Sleep and rest 3.3 ± 1.1 −.38 −.79 .43 .73
Psychological health (α = .81) 14.9 ± 3.0
Positive feelings 3.9 ± 1.0 −.92 .29 .66 .75
Concentration ability 3.5 ± .96 −.52 −.40 .46 .81
Bodily image self-acceptance 3.9 ± .96 −.91 .49 .52 .79
Self-satisfaction 3.8 ± 1.0 −.82 .16 .73 .73
Negative feelingsa 3.3 ± 1.0 −.11 −.71 .61 .77
Level of Independence (α = .67) 15.5 ± 3.2
Dependence on medicationa 3.4 ± 1.5 −.39 −1.3 .29 .79
Mobility 4.4 ± .81 − 1.6 2.9 .46 .62
Activities of daily living 3.9 ± .96 −.81 .25 .64 .51
Work capacity 3.7 ± 1.1 −.83 −.01 .60 .51
Social relations (α = .75) 15.0 ± 3.2
Social inclusion 4.1 ± .91 −1.1 1.3 .51 .71
Personal relationships 3.7 ± 1.0 −.73 −.03 .63 .64
Sexual satisfaction 3.2 ± 1.2 −.37 −.95 .46 .75
Social support 3.9 ± 1.0 −.96 .38 .61 .65
Environmental health (α = .81) 15.3 ± 2.5
Physical safety and security 3.7 ± .96 −.64 −.05 .54 .79
Physical environment 3.9 ± .90 −.93 .87 .57 .79
Financial resources 3.0 ± 1.0 −.24 −.64 .51 .79
Information for daily living 4.1 ± .84 −.90 .93 .56 .79
Participation in leisure activities 3.7 ± 1.0 −.68 −.23 .61 .78
Home environment 3.9 ± 1.0 −1.0 .82 .62 .78
Accessibility of health services 4.2 ± .80 − 1.0 1.1 .46 .80
Transport 3.8 ± 1.0 −.83 .29 .38 .81
Spirituality/Personal beliefs (α = .61) 14.5 ± 3.5
Personal life meaning 4.0 ± 1.0 −1.0 .49 .24 .63
Forgiveness and blamea 3.3 ± 1.6 −.33 −1.4 .32 .62
Concerns about the futurea 3.4 ± 1.2 −.36 −.88 .57 .40
Death and dyinga 3.7 ± 1.2 −.66 −.57 .47 .48
a Reversed items recoded
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WHOQOL-HIV Instrument Users Manual [30].
The skewness and kurtosis coefficients of most items
ranged from − 1.00 to 1.00. Some of them showed some-
what higher coefficients, but coefficients of less than 1.5can also be considered adequate [31]. The item showing
highest kurtosis (2.9) was the one measuring mobility.
The facets showing the lowest scores were financial
resources, sexual satisfaction, sleep and rest, negative
feelings, and forgiveness and blame. Across domains,
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highest scores while the SRPB domain presented the
lowest score.
Validity of the Spanish version of the WHOQOL-HIV-BREF
Construct validity
The results of the first-order CFA confirmed the six-
domain factor structure with an acceptable fit to the
data (Table 3). The results of the second-order CFA
confirmed the six first-order dimensions and one
second-order factor related to overall HRQoL, also
with acceptable model fit statistics. Most of the
standardized loadings were higher than 0.5, the level con-
sidered adequate [32]. However, lower loadings were
found in the facet dependence on medication in the Level
of Independence domain; the facet transport in the
Environmental Health domain; and the facets forgiveness
and blame and death and dying in the Spirituality.
Results of the alternative model tested (Model 2)
showed a high standardized loading for the item religion,
spirituality and personal beliefs in the Psychological
Health domain. Furthermore, the remaining three items
– forgiveness and blame, concerns about the future and
death and dying—showed higher loadings in the SRPB
latent factor than in Model 1 (Table 3). Moreover,
both first-order and second-order Model 2 showed a
substantial improvement in fit indexes. However, re-
sults of the second-order model showed that the
SRPB latent factor was the one with the lowest load-
ing in the high second-order latent factor related to
HRQoL (Table 3).
Internal consistency
Results of the different reliability coefficients were
calculated. These showed that internal consistency was
acceptable for most HRQoL dimensions (Table 4).
However, the SRPB domain showed the lowest reliability
coefficient. The Level of Independence domain showed
an alpha below expectations (< .70). Nevertheless, the
Omega coefficient (ω) showed an adequate value (.80),
because it is between .70 and .90 [33]. The Omega coef-
ficient, unlike the alpha coefficient, works with factorial
loads and it makes calculations more stable [34].
Convergent and concurrent validity
Positive and moderate to large correlations were found
between all domains and the General Health one that in-
dicated a good convergent validity. Religion and Personal
Beliefs domains (Table 3). The results of the covariances
among the first-order factors are presented in Table 5.
Regarding concurrent validity, positive correlations
were found between all HRQoL dimensions and ART
adherence and psychological well-being. Moreover,
negative correlations were found between HRQoLdimensions and negative self-image. However, there
was a moderate negative correlation with disclosure
concerns when correlated with the SRPB dimension
(Table 5).
Known-group validity
Significant differences were found according to partici-
pants’ self-reported CD4+ T cell count in several HRQoL
facets and domains (Table 6). The higher the CD4+ T cell
count, the higher the HRQoL scores. However, the effect
sizes of the differences were small. The highest ones were
found in the facets measuring participation in leisure ac-
tivities, financial resources, sexual satisfaction, symptoms
of HIV, and overall perception of health.
Some differences according to virological status
were also found. Those with undetectable viral load
presented significantly higher scores in the facets
measuring satisfaction with their own health, pain
and discomfort, sexual satisfaction and concerns about
the future, as well as marginally higher scores in
facets related to symptoms of HIV and participation
in leisure activities.
Differences in HRQoL according to the characteristics of
the participants
Women showed significantly lower scores than men in
several HRQoL facets (see Additional file 3 for further de-
tail). However, higher effect sizes were found in sexual
satisfaction (Cohen’s d = 0.64), bodily image self-
acceptance (Cohen’s d = 0.53), participation in leisure ac-
tivities (Cohen’s d = 0.49), pain and discomfort (Cohen’s
d = 0.44), and energy and fatigue (Cohen’s d = 0.43).
Regarding age, PLHIV older than 50 also presented
lower scores in several HRQoL facets. The greater differ-
ences were found in the items measuring sexual satisfac-
tion and work capacity (Cohen’s d = 0.47 and 0.37,
respectively). Nevertheless, older PLHIV showed higher
scores in the three HIV-specific items from the SRPB
domain (forgiveness and blame, concerns about the
future, death and dying) although the effect sizes of
these differences were small (Cohen’s d = − 0.13, − 0.11
and − 0.10, respectively).
The scores in all facets and the statistics assessing the
differences can be found in the supplementary material
(Additional file 3). Differences according to the other
socio-demographic characteristics revealed lower scores
in heterosexuals than homosexuals in all domains
(p < .0001) except in the SRPB domain. Bisexuals pre-
sented significant lower scores than homosexuals in
General Health (p < .0001), Physical Health (p < .0001),
Level of Independence (p < .0001), Social Relationships
(p < .001), and Environmental Health (p < .0001).
Moreover, the higher the level of education, the higher
the scores in all HRQoL domains (p < .0001) except in
Table 3 Standardized estimations for the six-domain first-order and HRQoL second-order structure Confirmatory Factor Analysis
(CFA) model
First Order (λ) Second Order (γ)
Domains and items Model 1 Model 2 Model 1 Model 2
Physical health .92 .93
Pain and discomforta .62 .63
Symptoms of HIVa .60 .60
Energy and fatigue .88 .88
Sleep and rest .65 .65
Psychological health .97 .94
Positive feelings .84 .85
Concentration ability .57 .57
Bodily image self-acceptance .67 .68
Self-satisfaction .86 .87
Negative feelingsa .69 .70
Religion, spirituality and personal beliefs (personal life meaning) – .81
Level of Independence .94 .94
Dependence on medicationa .38 .39
Mobility .73 .73
Activities of daily living .87 .87
Work capacity .81 .81
Social relations .91 .91
Social inclusion .70 .70
Personal relationships .81 .81
Sexual satisfaction .65 .65
Social support .71 .71
Environmental health .92 .92
Physical safety and security .82 .81
Physical environment .69 .69
Financial resources .56 .56
Information for daily living .69 .69
Participation in leisure activities .74 .74
Home environment .71 .71
Accessibility of health services .51 .51
Transport .40 .40
Spirituality/Personal beliefs .86 .50
Religion, spirituality and personal beliefs (personal life meaning) .89 –
Forgiveness and blamea .36 .56
Concerns about the futurea .51 .87
Death and dyinga .35 .60
SB-χ2 (Satorra-Bentler Chi-square) 3210.71 2691.78 3435.87 2906.40
Degrees of freedom 362 362 370 370
p < .001 < .001 < .001 < .001
RMSEA (IC 90%) 0.073 (0.071; 0.076) 0.066 (0.064; 0.069) 0.075 (0.073; 0.078) 0.068 (0.066; 0.071)
SRMR 0.064 0.058 0.068 0.062
GFI 0.98 0.98 0.98 0.98
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Table 3 Standardized estimations for the six-domain first-order and HRQoL second-order structure Confirmatory Factor Analysis
(CFA) model (Continued)
First Order (λ) Second Order (γ)
Domains and items Model 1 Model 2 Model 1 Model 2
AGFI 0.97 0.98 0.97 0.98
CFI 0.97 0.97 0.97 0.97
NFI 0.97 0.97 0.97 0.97
CAIC 3815.70 3296.77 3974.56 3445.10
Notes: N = 1462. Estimation of the robust unweighted least squares. SB-χ2: Satorra-Bentler Chi-square. df: degrees of freedom. Model 1: dimensions according to
the original scale. Model 2: allowing the item religion, spirituality and personal beliefs (feeling that life is meaningful) to load in the Psychological Health domain
instead of the SRPB domain
a Reversed items recoded
All factor loadings p < .05
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found between participants’ incomes and all dimensions
of HRQoL (ranging from r = .11 in the SRPB domain to
r = .36 in the Environmental Health domain; p < .01).
Furthermore, participants who acquired HIV infection
through the injection route presented the lower scores
in HRQoL domains (p < .0001) except in the SRPB
domain.
Finally, negative correlations were found between
most HRQoL dimensions (except the SRPB domain)
and years since diagnosis (ranging from r = − 15 in
the Social Relationship domain to r = − .27 in Physical
domain; p < .01).
Discussion
This study assessed the validity of the Spanish version of
WHOQOL-HIV-BREF. It also described HRQoL in
PLHIV living in Spain and the more vulnerable profiles.
Regarding its validity, the instrument showed ac-
ceptable construct validity although some minor
changes could improve it. The SRPB domain showed
the lowest reliability. In line with other studies [17,
18], the item religion, spirituality and personal beliefs
(feeling that life is meaningful), was the one with the
lowest item-domain correlation. Some authors have
suggested including this item in the Psychological
Health domain [16, 35]. The results of the present
study support this modification.Table 4 Reliability coefficients of the domains of the WHOQOL-HIV-
Dimensions Cronbach’s alpha Spearman-Brown (ρ)
Overall QoL/General Health .77 .775
Physical health .73 .662
Psychological health .81 .842
Level of Independence .67 .638
Social relations .75 .785
Environmental health .81 .809
Spirituality/Personal beliefs .61 .547The instrument also showed concurrent validity. In
line with findings from other studies [17, 36], all of its
dimensions were positively related to ART adherence
and psychological well-being. At the same time, all of
the HRQoL dimensions were negatively related to nega-
tive self-image, and the SRPB domain was the unique di-
mension that was significantly and negatively related to
disclosure concerns. People who have a stigmatized con-
dition may find some advantages in concealing the con-
dition, but concealment may also result in mental strain
and poorer psychological well-being [37, 38]. Thus, the
results of this highlighted the relevance of the SRBP
HIV-specific items, despite the low discriminant capabil-
ity of this dimension.
The instrument was able to discriminate according to
self-reported immunological and virological statuses in
several HRQoL facets. This finding is in line with evi-
dence from other studies [8, 14, 39, 40], although not all
studies have had the same finding [15, 17].
The present study also described the HRQoL of
PLHIV in Spain. Financial resources and sexual satisfac-
tion were the most impaired facets. Both facets were
found to be related to HRQoL in a previous Spanish
study, but financial problems showed in that study the
highest correlation [6]. Sociodemographic data collected
from our participants revealed that they were in a pre-
carious financial situation, and it could be damaging
their HRQoL. Although Physical Health was one of theBREF
Guttman
Split-half
MCDonald’s composite score (ω) Intraclass correlation [IC]
.772 .77 [.747, .794]
.660 .786 .734 [.711, .756]
.827 .851 .812 [.796, .827]
.638 .803 .678 [.650, .704]
.779 .810 .749 [.728, .770]
.809 .851 .816 [.801, .830]
.545 .623 .61 [.579, .644]
Table 5 Covariances (ϕ) between the Spanish WHOQOL-HIV-BREF dimensions and correlations between these dimensions and
criterion variables
Covariances (ϕ) Pearson’s Correlations (r)








PHY 1 .90 .96 .75 .83 .81 .67** .44** .63** −.33** −.04
PSY 1 .87 .89 .86 .95 .66** .42** .74** −.44** −.07*
IND 1 .79 .89 .74 .61** .36** .58** −.31** .00
SR 1 .90 .81 .56** .39** .57** −.33** −.07*
EH 1 .72 .65** .47** .57** −.33** −.01
SRPB 1 .41** .29** .53** −.55** −.30**
GH 1 .44** .58** −.29** −.02
Notes: GH = General Health, PHY = Physical Domain, PSY = Psychological Domain, IND = Level of Independence Domain, SR = Social Relations Domain, EH =
Environmental Health Domain, SRPB = Spirituality, Religion and Personal Beliefs Domain. α = Cronbach’s alpha reliability coefficient
N = 1462. ** p < .01. * p < .05
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and rest had one of the lowest facet scores. This result
was also found in other studies conducted in other
countries [8, 14, 17, 41]. Also, HIV-specific existential
concerns and negative feelings were among the most af-
fected HRQoL facets. HIV-specific existential concerns
included in the WHOQOL-HIV-BREF are related to
stigma and concerns about the future and death. Re-
search showed that there are prejudices towards PLHIV
in Spain [42] and that both enacted and internalized
stigma were related to poor HRQoL [6, 37]. Further-
more, research also showed that emotional loneliness,
HIV-related stress and depressive mood were negatively
related to HRQoL of PLHIV in Spain [6]. Stigma, de-
pression, anxiety and other variables not measured in
the present study such as comorbidities, social support,
family situation or lifestyle are found to be determinants
of PLHIV’s HRQoL [5]. All these variables might explain
the concerns and negative feelings of the participants in
the present study. Correlations found between psycho-
logical well-being, HIV-related stigma and HRQoL di-
mensions in this study support it.
Moreover, our results suggest that specific sub-
groups of PLHIV in Spain are particularly vulnerable
to poor health-related quality of life for HRQoL. We
found lower HRQoL scores for people who had been
living with HIV for a longer time, in older people
and in heterosexuals. Although incidence of hetero-
sexual transmission of HIV has been decreasing in
Spain in recent years, people whose HIV infection is
attributed to this mode of transmission are estimated
to constitute one-third of all PLHIV nationally [43].
Furthermore, Spain is estimated to have large propor-
tions of PLHIV who are older than 50 years (46%)
and who were diagnosed with HIV more than 15
years ago (49%) [43]. Older age and a longer periodof time living with HIV are both associated with
higher prevalence of non-HIV-related comorbidities
such as diabetes and chronic kidney disease [44, 45].
The long-term management of multiple comorbidities,
in turn, gives rise to high levels of polypharmacy [46].
Comborbidities and polypharmacy both have the
potential to undermine HRQoL [47].
According to our findings, acquiring HIV through in-
jection drug use is another factor associated with poorer
HRQoL. While HIV transmission via the sharing of un-
sterile injection drug equipment is decreasing in Spain,
31% of PLHIV are estimated to belong to this transmis-
sion category [43]. We also found lower socioeconomic
and educational status to be related to poorer HRQoL,
and women in our study had lower HRQoL than their
male counterparts. The role of aging should be consid-
ered in terms of how it specifically affects the HRQoL of
women living with HIV, and it is notable that some of
the most impaired HRQoL facets found in the present
research might be exacerbated by menopause [48, 49].
Our study findings lead us to propose that initia-
tives to improve the HRQoL of PLHIV might have
the greatest impact if they target specific populations
and take into account both structural, psychosocial,
and biomedical drivers of poor HRQoL. Interventions
that can improve HRQoL through mechanisms such
as social support and self-empowerment may have
far-reaching consequences for individual PLHIV and
for health systems. A recent longitudinal study found
that both physical and mental HRQoL dimensions’
scores were predictive of all-cause hospitalization in a
cohort of PLHIV, suggesting that improving HRQoL
in this population can result in better health out-
comes [50].
The main limitation of our study derives from its
cross-sectional nature. Another limitation is the self-
Table 6 Known-group comparisons of the WHOQOL-HIV-BREF scores












Domains and items Mean ± SD Mean ± SD Mean ± SD p-Value η2 Mean ± SD Mean ± SD p-Value
Overall QoL/General Health 13.8 ± 3.8 14.1 ± 3.7 15.2 ± 3.5 .000 0.014 15.1 ± 3.5 14.2 ± 4.2 .128 0.253
How would you rate
your QoL?
3.3 ± 1.2 3.4 ± 1.1 3.7 ± 1.0 .000 0.012 3.7 ± 1.1 3.5 ± 1.2 .279 0.180
How satisfied are you
with your health?
3.7 ± 1.1 3.7 ± 1.0 3.9 ± 0.9 .002 0.010 3.9 ± 0.9 3.6 ± 1.1 .050 0.328
Physical health 14.7 ± 3.5 15.0 ± 3.2 15.6 ± 3.2 .004 0.008 15.6 ± 3.2 14.8 ± 3.7 .084 0.247
Pain and discomforta 3.8 ± 1.3 3.9 ± 1.2 4.0 ± 1.2 .312 0.002 4.0 ± 1.2 3.8 ± 1.3 .069 0.165
Symptoms of HIVa 3.9 ± 1.2 4.1 ± 1.2 4.3 ± 1.1 .001 0.014 4.3 ± 1.1 4.0 ± 1.1 .078 0.272
Energy and fatigue 3.7 ± 1.1 3.8 ± 0.9 4.0 ± 1.0 .044 0.005 3.9 ± 1.0 3.9 ± 1.0 .511 0
Sleep and rest 3.3 ± 1.2 3.3 ± 1.1 3.4 ± 1.2 .190 0.002 3.4 ± 1.1 3.2 ± 1.3 .143 0.179
Psychological health 14.8 ± 3.2 14.7 ± 2.9 15.1 ± 3.0 .322 0.001 15.0 ± 3.0 14.8 ± 3.3 .633 0.066
Positive feelings 3.8 ± 1.2 3.8 ± 1.0 4.0 ± 1.0 .019 0.001 4.0 ± 1.0 3.9 ± 1.2 .575 0.009
Concentration ability 3.7 ± 0.8 3.5 ± 1.0 3.6 ± 1.0 .326 0.002 3.6 ± 1.0 3.6 ± 1.0 .708 0
Bodily image
self-acceptance
4.0 ± 1.1 3.9 ± 1.0 4.0 ± 1.0 .781 0.000 4.0 ± 0.9 4.0 ± 1.0 .833 0
Self-satisfaction 3.9 ± 1.2 3.8 ± 1.0 3.9 ± 1.0 .695 0.000 3.9 ± 1.0 3.8 ± 1.1 .396 0.099
Negative feelingsa 3.1 ± 1.1 3.4 ± 1.0 3.3 ± 1.1 .139 0.004 3.4 ± 1.1 3.2 ± 1.1 .134 0.181
Level of Independence 14.8 ± 3.5 14.7 ± 3.1 15.7 ± 3.1 .000 0.011 15.6 ± 3.1 15.3 ± 3.4 .478 0.096
Dependence on
medicationa
3.1 ± 1.5 3.1 ± 1.4 3.5 ± 1.5 .003 0.009 3.4 ± 1.5 3.3 ± 1.5 .440 0.066
Mobility 4.4 ± 0.9 4.4 ± 0.8 4.5 ± 0.8 .081 0.003 4.5 ± 0.8 4.5 ± 0.8 .969 0
Activities of daily living 3.7 ± 1.1 3.7 ± 0.9 4.0 ± 0.9 .004 0.007 3.9 ± 0.9 3.8 ± 1.0 .457 0.110
Work capacity 3.6 ± 1.3 3.6 ± 1.2 3.8 ± 1.1 .082 0.003 3.8 ± 1.1 3.7 ± 1.2 .520 0.090
Social relations 14.5 ± 3.9 14.6 ± 3.1 15.1 ± 3.1 .075 15.1 ± 3.2 14.4 ± 3.7 .081 0.216
Social inclusion 4.1 ± 1.0 4.2 ± 0.9 4.1 ± 0.9 .985 0.000 4.2 ± 0.9 4.0 ± 1.0 .161 0.220
Personal relationships 3.7 ± 1.2 3.8 ± 1.0 3.8 ± 1.0 .942 0.000 3.8 ± 1.0 3.8 ± 1.2 .822 0
Sexual satisfaction 2.8 ± 1.5 2.9 ± 1.3 3.3 ± 1.3 .000 0.013 3.3 ± 1.3 2.9 ± 1.4 .003 0.306
Social support 3.8 ± 1.3 3.8 ± 1.0 4.0 ± 1.0 .308 0.001 3.9 ± 1.0 3.7 ± 1.2 .111 0.197
Environmental health 14.7 ± 2.9 15.0 ± 2.3 15.5 ± 2.4 .005 0.003 15.4 ± 2.5 15.0 ± 2.7 .244 0.159
Physical safety and
security
3.6 ± 1.1 3.7 ± 0.9 3.8 ± 0.9 .196 0.003 3.8 ± 0.9 3.6 ± 1.0 .306 0.220
Physical environment 3.8 ± 1.0 3.9 ± 0.9 4.0 ± 0.9 .279 0.002 4.0 ± 0.9 3.8 ± 1.1 .145 0.218
Financial resources 2.7 ± 1.1 3.0 ± 1.0 3.2 ± 1.1 .000 0.015 3.1 ± 1.1 3.0 ± 1.2 .241 0.090
Information for daily
living
4.0 ± 1.0 4.1 ± 0.8 4.1 ± 0.8 .681 0.001 4.1 ± 0.8 4.1 ± 0.9 .754 0
Participation in leisure
activities
3.5 ± 1.3 3.5 ± 1.1 3.9 ± 1.0 .000 0.019 3.8 ± 1.1 3.6 ± 1.2 .081 0.180
Home environment 3.9 ± 1.2 3.9 ± 1.0 4.0 ± 1.0 .374 0.001 4.0 ± 1.0 3.9 ± 1.1 .353 0.099
Accessibility of health
services
4.4 ± 0.8 4.1 ± 0.9 4.2 ± 0.8 .111 0.003 4.2 ± 0.8 4.3 ± 0.9 .538 −0.124
Transport 3.7 ± 1.2 3.9 ± 1.0 3.9 ± 1.0 .337 0.002 3.9 ± 1.0 3.9 ± 1.0 .562 0
SRPB 14.0 ± 3.4 14.9 ± 3.3 14.5 ± 3.5 .209 0.002 14.6 ± 3.5 14.1 ± 3.7 .213 0.142
Personal life meaning 4.0 ± 1.2 4.0 ± 1.0 4.1 ± 1.0 .451 0.001 4.1 ± 1.0 4.1 ± 1.1 .926 0
Forgiveness and blamea 2.8 ± 1.7 3.7 ± 1.5 3.3 ± 1.6 .001 0.010 3.3 ± 1.6 3.3 ± 1.6 .974 0
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Table 6 Known-group comparisons of the WHOQOL-HIV-BREF scores (Continued)












Domains and items Mean ± SD Mean ± SD Mean ± SD p-Value η2 Mean ± SD Mean ± SD p-Value
Concerns about the futurea 3.5 ± 1.3 3.5 ± 1.2 3.4 ± 1.3 .771 0.000 3.5 ± 1.2 3.2 ± 1.4 .024 0.247
Death and dyinga 3.7 ± 1.4 3.8 ± 1.2 3.7 ± 1.2 .685 0.000 3.7 ± 1.2 3.5 ± 1.4 .283 0.164
Notes: SRPB Spirituality, Religion and Personal Beliefs. η2 = F-test effect size. Cohen’s d = t-test effect size. Near to 4% (N = 54) of the participants stated not
knowing their viral load copies, and 16.6% (N = 243) stated being unsure of the amount of CD4 + T cells
a Reversed items recoded
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since people may not correctly recall information such
as their viral load level. The large sample size of our
study led to many findings of statistically significant
differences between groups. Although we reported the
effect sizes, the cross-sectional nature of our study did
not allow us to test how such differences have an impact
on clinical outcomes. Thus, future longitudinal studies
should be conducted analyzing data collected from clin-
ical records. This would allow for assessment of the pre-
dictive validity of the instrument and thus would
provide stronger evidence than the findings of the
present study, as well as showing which facets and di-
mensions of HRQoL have the most substantial impact
on clinical outcomes. Such evidence also could be used
to guide interventions to address the needs of the most
vulnerable populations in regard to the issues that are
having the greatest negative effect on their health and
HRQoL. In addition, the heterogeneity of PLHIV and
the differences found point to the need to analyze scale
invariances across sex, age and other relevant character-
istics. Also, our study has the limitation that the popula-
tion was recruited by convenience sampling. This affects
the representativeness of the sample. However, the large
sample size of our study could offset this limitation, as
demonstrated by the finding that the characteristics of
our participants were concordant with Spanish epi-
demiological data for PLHIV. Finally, our study did not
include PLHIV having any severe psychiatric or cogni-
tive disorder. This was because survey respondents were
required to have sufficient cognitive capacity to answer
the questionnaires [51]. However, there is a need to im-
plement strategies to facilitate the participation of
PLHIV who suffer from those disorders because they
may be underrepresented in quality-of-life assessments,
and their needs and experiences may not be taken into
account in interventions to improve quality of life.
Conclusions
This study demonstrates the validity and reliability of
the Spanish version of WHOQOL-HIV-BREF. It also
provides evidence about HRQoL in PLHIV in Spain by
using the largest study sample to date. Long-termsurvivors, older adults, and women are key populations
to address in order to improve HRQoL. Monitoring of
HRQoL and taking steps to help patients with poor
HRQoL can result in better overall health outcomes.
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